跳至主要内容
临床试验/IRCT20220115053723N1
IRCT20220115053723N1已完成2 期

comparison study of the effects of duloxetine and venlafaxine on neuropathy in breast cancer patients with taxol-induced acute peripheral neuropathy

Tehran University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
Female

入选标准

  • patients with breast cancer who treated with taxol (paclitaxel) for chemotherapy with peripheral neuropathic and neuropathic pain with confirmation of physical examination
  • pain score 3 or more according to MacGill questionnaire
  • No metastasis
  • life expectancy more than 3 months
  • Hospital anxiety and depression scale score less than 20 according to HADS questionnaire
  • Neuropathic score more than 3 in DN4 questionnaire.

排除标准

  • metastatic breast cancer
  • pregnancy and breast feeding
  • HADS score more than 20
  • using antidepressant and anti epileptic drugs and opioids
  • paralytic neuropathic syndromes

研究者

相似试验